Local increase in microparticles from the aspirate of culprit coronary arteries in patients with ST-segment elevation myocardial infarction

Atherosclerosis

Volumn 227, Issue 2, 2013, Pages 323-328

  Min, Pil Ki ^a   Kim, Jong Youn ^a   Chung, Kwang Hoe ^b   Lee, Byoung Kwon ^a   Cho, Minhee ^a   Lee, Da Lyung ^c   Hong, Sung Yu ^c   Choi, Eui Young ^a   Yoon, Young Won ^a   Hong, Bum Kee ^a   Rim, Se Joong ^a   Kwon, Hyuck Moon ^a  

^a Yonsei University College of Medicine   (South Korea)

^b CHA University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Atherosclerotic plaque; Cell derived microparticles; Coronary thrombosis; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBODY; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; PHOSPHATIDYLSERINE;

ADULT; ARTICLE; ASSAY; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIAL MICROPARTICLE; FEMALE; FEMORAL ARTERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMBRANE MICROPARTICLE; PERCUTANEOUS CORONARY INTERVENTION; PLATELET MICROPARTICLE; PRIORITY JOURNAL; SOLID PHASE CAPTURE ASSAY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; BLOOD PLATELETS; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; COAGULANTS; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY VESSELS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PHOSPHATIDYLSERINES; PLAQUE, ATHEROSCLEROTIC; PROSPECTIVE STUDIES; THROMBOSIS; TIME FACTORS;

EID: 84875055035     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.01.032     Document Type: Article

References (17)

1. VanWijk M.J., VanBavel E., Sturk A., Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 2003, 59:277-287.
2. Puddu P., Puddu G.M., Cravero E., Muscari S., Muscari A. The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases. Can J Cardiol 2010, 26:140-145.
3. Mallat Z., Benamer H., Hugel B., et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000, 101:841-843.
4. Bernal-Mizrachi L., Jy W., Jimenez J.J., et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 2003, 145:962-970.
5. Bernal-Mizrachi L., Jy W., Fierro C., et al. Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes. Int J Cardiol 2004, 97:439-446.
6. Morel O., Hugel B., Jesel L., et al. Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists. J Thromb Haemost 2004, 2:1118-1126.
7. Morel O., Pereira B., Averous G., et al. Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: role of endothelial damage and leukocyte activation. Atherosclerosis 2009, 204:636-641.
8. Alpert J.S., Thygesen K., Antman E., Bassand J.P. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000, 36:959-969.
9. Jy W., Horstman L.L., Jimenez J.J., et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004, 2:1842-1851.
10. Mallat Z., Hugel B., Ohan J., Leseche G., Freyssinet J.M., Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 1999, 99:348-353.
11. Bonderman D., Teml A., Jakowitsch J., et al. Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque. Blood 2002, 99:2794-2800.
12. Leroyer A.S., Isobe H., Leseche G., et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol 2007, 49:772-777.
13. Hoshiba Y., Hatakeyama K., Tanabe T., Asada Y., Goto S. Co-localization of von Willebrand factor with platelet thrombi, tissue factor and platelets with fibrin, and consistent presence of inflammatory cells in coronary thrombi obtained by an aspiration device from patients with acute myocardial infarction. J Thromb Haemost 2006, 4:114-120.
14. Ko Y.G., Jung J.H., Park S., et al. Inflammatory and vasoactive factors in the aspirate from the culprit coronary artery of patients with acute myocardial infarction. Int J Cardiol 2006, 112:66-71.
15. Simak J., Gelderman M.P., Yu H., Wright V., Baird A.E. Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J Thromb Haemost 2006, 4:1296-1302.
16. Suzuki H., Kusuyama T., Sato R., et al. Elevation of matrix metalloproteinases and interleukin-6 in the culprit coronary artery of myocardial infarction. Eur J Clin Invest 2008, 38:166-173.
17. Porto I., Biasucci L.M., De Maria G.L., et al. Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention. Eur Heart J 2012, 33:2928-2938.